Trial Profile
A Randomized Controlled Trial To Compare The Immunogenicity Of Self-Administered And Nurse-Administered Intradermal Influenza Vaccine.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Feb 2017
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 14 Jun 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 27 Oct 2010 New trial record